Literature DB >> 17160057

Where have all the antibiotic patents gone?

Martin L Katz1, Lisa V Mueller, Mark Polyakov, Steven F Weinstock.   

Abstract

Patent and regulatory hurdles combined with low returns on investment are stifling antibiotic R&D in the pharmaceutical industry.

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 17160057     DOI： 10.1038/nbt1206-1529

Source DB:  PubMed          Journal:  Nat Biotechnol        ISSN： 1087-0156            Impact factor:   54.908


  16 in total

Review 1.  Challenges of antibacterial discovery.

Authors:  Lynn L Silver
Journal:  Clin Microbiol Rev       Date:  2011-01       Impact factor: 26.132

2.  Public funding of clinical-stage antibiotic development in the United States and European Union.

Authors:  Michael J Eichberg
Journal:  Health Secur       Date:  2015 May-Jun

3.  QCM-D fingerprinting of membrane-active peptides.

Authors:  George A McCubbin; Slavica Praporski; Stefania Piantavigna; Daniel Knappe; Ralf Hoffmann; John H Bowie; Frances Separovic; Lisandra L Martin
Journal:  Eur Biophys J       Date:  2010-12-16       Impact factor: 1.733

4.  Production of macrolide antibiotics from a cytotoxic soil Streptomyces sp. strain ZDB.

Authors:  Zerihun T Dame; Pornthip Ruanpanun
Journal:  World J Microbiol Biotechnol       Date:  2017-06-05       Impact factor: 3.312

5.  Fluoroquinolones in community-acquired pneumonia: guide to selection and appropriate use.

Authors:  Christopher R Frei; Matthew J Labreche; Russell T Attridge
Journal:  Drugs       Date:  2011-04-16       Impact factor: 9.546

6.  A new antibiotic with potent activity targets MscL.

Authors:  Irene Iscla; Robin Wray; Paul Blount; Jonah Larkins-Ford; Annie L Conery; Frederick M Ausubel; Soumya Ramu; Angela Kavanagh; Johnny X Huang; Mark A Blaskovich; Matthew A Cooper; Andres Obregon-Henao; Ian Orme; Edwin S Tjandra; Uwe H Stroeher; Melissa H Brown; Cindy Macardle; Nick van Holst; Chee Ling Tong; Ashley D Slattery; Christopher T Gibson; Colin L Raston; Ramiz A Boulos
Journal:  J Antibiot (Tokyo)       Date:  2015-02-04       Impact factor: 2.649

7.  Application of Nanoparticle Technology to Reduce the Anti-Microbial Resistance through β-Lactam Antibiotic-Polymer Inclusion Nano-Complex.

Authors:  Constain H Salamanca; Cristhian J Yarce; Yony Roman; Andrés F Davalos; Gustavo R Rivera
Journal:  Pharmaceuticals (Basel)       Date:  2018-02-10

Review 8.  Antimicrobial and Antibiofilm Peptides.

Authors:  Angela Di Somma; Antonio Moretta; Carolina Canè; Arianna Cirillo; Angela Duilio
Journal:  Biomolecules       Date:  2020-04-23

9.  Antibacterial and antiyeast compounds from marine-derived bacteria.

Authors:  Muhammad Abdul Mojid Mondol; Hee Jae Shin
Journal:  Mar Drugs       Date:  2014-05-13       Impact factor: 5.118

Review 10.  The Revaluation of Plant-Derived Terpenes to Fight Antibiotic-Resistant Infections.

Authors:  Floriana Cappiello; Maria Rosa Loffredo; Cristina Del Plato; Silvia Cammarone; Bruno Casciaro; Deborah Quaglio; Maria Luisa Mangoni; Bruno Botta; Francesca Ghirga
Journal:  Antibiotics (Basel)       Date:  2020-06-13
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.